308 related articles for article (PubMed ID: 16227401)
21. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.
Stiehl DP; Fath DM; Liang D; Jiang Y; Sang N
Cancer Res; 2007 Mar; 67(5):2256-2264. PubMed ID: 17332356
[TBL] [Abstract][Full Text] [Related]
22. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
23. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.
Wong K; Sharma A; Awasthi S; Matlock EF; Rogers L; Van Lint C; Skiest DJ; Burns DK; Harrod R
J Biol Chem; 2005 Mar; 280(10):9390-9. PubMed ID: 15611041
[TBL] [Abstract][Full Text] [Related]
25. Assays for Validating Histone Acetyltransferase Inhibitors.
Waddell AR; Liao D
J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831305
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
[TBL] [Abstract][Full Text] [Related]
28. Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities.
Dedes KJ; Dedes I; Imesch P; von Bueren AO; Fink D; Fedier A
Anticancer Drugs; 2009 Jun; 20(5):321-33. PubMed ID: 19322073
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening.
Zhang R; Wang J; Zhao L; Liu S; Du D; Ding H; Chen S; Yue L; Liu YC; Zhang C; Liu H; Luo C
Eur J Med Chem; 2018 Sep; 157():867-876. PubMed ID: 30145373
[TBL] [Abstract][Full Text] [Related]
30. Histone H1 is a specific repressor of core histone acetylation in chromatin.
Herrera JE; West KL; Schiltz RL; Nakatani Y; Bustin M
Mol Cell Biol; 2000 Jan; 20(2):523-9. PubMed ID: 10611231
[TBL] [Abstract][Full Text] [Related]
31. CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells.
Trisciuoglio D; Ragazzoni Y; Pelosi A; Desideri M; Carradori S; Gabellini C; Maresca G; Nescatelli R; Secci D; Bolasco A; Bizzarri B; Cavaliere C; D'Agnano I; Filetici P; Ricci-Vitiani L; Rizzo MG; Del Bufalo D
Clin Cancer Res; 2012 Jan; 18(2):475-86. PubMed ID: 22068659
[TBL] [Abstract][Full Text] [Related]
32. Multiple roles for acetylation in the interaction of p300 HAT with ATF-2.
Karanam B; Wang L; Wang D; Liu X; Marmorstein R; Cotter R; Cole PA
Biochemistry; 2007 Jul; 46(28):8207-16. PubMed ID: 17590016
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of histone acetyltransferase by glycosaminoglycans.
Buczek-Thomas JA; Hsia E; Rich CB; Foster JA; Nugent MA
J Cell Biochem; 2008 Sep; 105(1):108-20. PubMed ID: 18459114
[TBL] [Abstract][Full Text] [Related]
34. A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation.
Hardcastle A; Tomlin P; Norris C; Richards J; Cordwell M; Boxall K; Rowlands M; Jones K; Collins I; McDonald E; Workman P; Aherne W
Mol Cancer Ther; 2007 Mar; 6(3):1112-22. PubMed ID: 17363504
[TBL] [Abstract][Full Text] [Related]
35. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK.
Ko SI; Lee IS; Kim JY; Kim SM; Kim DW; Lee KS; Woo KM; Baek JH; Choo JK; Seo SB
FEBS Lett; 2006 May; 580(13):3217-22. PubMed ID: 16696975
[TBL] [Abstract][Full Text] [Related]
36. Application of a fluorescent histone acetyltransferase assay to probe the substrate specificity of the human p300/CBP-associated factor.
Trievel RC; Li FY; Marmorstein R
Anal Biochem; 2000 Dec; 287(2):319-28. PubMed ID: 11112280
[TBL] [Abstract][Full Text] [Related]
37. Valproic acid exposure decreases Cbp/p300 protein expression and histone acetyltransferase activity in P19 cells.
Lamparter CL; Winn LM
Toxicol Appl Pharmacol; 2016 Sep; 306():69-78. PubMed ID: 27381264
[TBL] [Abstract][Full Text] [Related]
38. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
39. Histone acetylation by p300 is involved in CREB-mediated transcription on chromatin.
Yuan LW; Gambee JE
Biochim Biophys Acta; 2001 Dec; 1541(3):161-9. PubMed ID: 11755210
[TBL] [Abstract][Full Text] [Related]
40. Kinetic and mass spectrometric analysis of p300 histone acetyltransferase domain autoacetylation.
Karanam B; Jiang L; Wang L; Kelleher NL; Cole PA
J Biol Chem; 2006 Dec; 281(52):40292-301. PubMed ID: 17065153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
